脐带血浆代谢物与出生体重的关联:发现队列与验证队列的代谢组学和脂质组学研究
在武汉健康婴儿队列的504例脐带血发现集中,513种代谢物与出生体重Z评分显著相关,初级胆汁酸合成通路最相关;350例验证集靶向分析显示,脐带血浆TCDCA和TCA每增加2倍,出生体重Z评分降低,SGA风险升高。
要点
- 脐带血浆初级胆汁酸升高与出生体重Z评分降低相关。
- 验证集中TCDCA和TCA每增加2倍与SGA风险升高相关。
- 初级胆汁酸代谢异常可能在胎儿生长受限中起重要作用。
核心结论
- 脐带血中初级胆汁酸(尤其是TCDCA和TCA)升高与出生体重Z评分降低及SGA和LBW风险增加显著相关。
研究设计与样本
- 两阶段发现与验证研究;发现集来自中国武汉健康婴儿队列的504例脐带血样本,采用伪靶向代谢组学检测;验证集350例脐带血样本进行靶向分析。
诊断标准与关键数值
- 发现集检测2566种代谢物,数据预处理后保留2418种进行分析,其中513种与出生体重Z评分显著相关(PFDR<0.05),298种KEGG注释代谢物纳入通路分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Birth weight is a good predictor of fetal intrauterine growth and long-term health, and several studies have evaluated the relationship between metabolites and birth weight. The aim of this study was to investigate the association of cord blood metabolomics and lipidomics with birth weight, using a two-stage discovery and validation approach.
METHODS: Firstly, a pseudotargeted metabolomics approach was applied to detect metabolites in 504 cord blood samples in the discovery set enrolled from the Wuhan Healthy Baby Cohort, China. Metabolome-wide association scan analysis and pathway enrichment were applied to identify metabolites and metabolic pathways that were significantly associated with birth weight adjusted for gestational age Z-score (BW Z-score). Logistic regression models were used to analyze the association of metabolites in the most significantly associated pathways with small-for-gestational age (SGA) at delivery and low birth weight (LBW). Subsequently, 350 cord blood samples in a validation cohort were subjected to targeted analysis to validate the metabolites identified by screening in the discovery cohort.
RESULTS: In the discovery set, of 2566 metabolites detected, 2418 metabolites were retained for subsequent analysis after data preprocessing. Of these, 513 metabolites were significantly associated with BW Z-score (P-value adjusted for false discovery rate (PFDR) < 0.05), of which 298 Kyoto Encyclopedia of Genes and Genomes (KEGG)-annotated metabolites were included in the pathway analysis. The primary bile acid biosynthesis pathway was the most relevant metabolic pathway associated with BW Z-score. Elevated cord plasma primary bile acids were associated with lower BW Z-score and higher risk of SGA or LBW in the discovery and validation cohorts. In the validation set, a 2-fold increase in taurochenodeoxycholic acid (TCDCA) and in taurocholic acid (TCA) was associated with a decrease in BW Z-score (estimated β coefficient, -0.10 (95% CI, -0.20 to 0.00) and -0.18 (95% CI, -0.31 to -0.04), respectively), after adjusting for covariates. In addition, a 2-fold increase in cord plasma TCDCA and of cord plasma TCA was associated with an increased risk of SGA (adjusted odds ratio (OR), 1.52 (95% CI, 1.00-2.30) and 1.77 (95% CI, 1.05-2.98), respectively). The adjusted OR for LBW, for a 2-fold increase in TCDCA and TCA concentration, were 2.39 (95% CI, 1.00-5.71) and 3.21 (95% CI, 0.96-10.74), respectively.
CONCLUSIONS: These results indicate a significant association of elevated primary bile acids, particularly TCDCA and TCA, in cord blood with lower BW Z-score, as well as increased risk of SGA and LBW. Abnormalities of primary bile acid metabolism may play an important role in restricted fetal development. © 2024 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Xie Y, Fang X, Wang A, et al. Association of cord plasma metabolites with birth weight: results from metabolomic and lipidomic studies of discovery and validation cohorts. Ultrasound Obstet Gynecol. 2024. PMID: 38243991. doi:10.1002/uog.27591
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。